- Home
- DUO vs KTTA Comparison
DUO vs KTTA Comparison
Compare DUO & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DUO
- KTTA
- Stock Information
- Founded
- DUO 2011
- KTTA 2020
- Country
- DUO China
- KTTA United States
- Employees
- DUO N/A
- KTTA N/A
- Industry
- DUO Real Estate
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- DUO Finance
- KTTA Health Care
- Exchange
- DUO Nasdaq
- KTTA Nasdaq
- Market Cap
- DUO 6.1M
- KTTA 5.7M
- IPO Year
- DUO 2019
- KTTA 2021
- Fundamental
- Price
- DUO $1.89
- KTTA $0.72
- Analyst Decision
- DUO
- KTTA
- Analyst Count
- DUO 0
- KTTA 0
- Target Price
- DUO N/A
- KTTA N/A
- AVG Volume (30 Days)
- DUO 486.0K
- KTTA 79.1K
- Earning Date
- DUO 11-19-2025
- KTTA 11-14-2025
- Dividend Yield
- DUO N/A
- KTTA N/A
- EPS Growth
- DUO N/A
- KTTA N/A
- EPS
- DUO N/A
- KTTA N/A
- Revenue
- DUO $56,189,313.00
- KTTA N/A
- Revenue This Year
- DUO N/A
- KTTA N/A
- Revenue Next Year
- DUO N/A
- KTTA N/A
- P/E Ratio
- DUO N/A
- KTTA N/A
- Revenue Growth
- DUO 48.30
- KTTA N/A
- 52 Week Low
- DUO $1.24
- KTTA $0.65
- 52 Week High
- DUO $27.68
- KTTA $4.35
- Technical
- Relative Strength Index (RSI)
- DUO 33.06
- KTTA 46.19
- Support Level
- DUO $2.60
- KTTA $0.69
- Resistance Level
- DUO $2.90
- KTTA $0.78
- Average True Range (ATR)
- DUO 0.27
- KTTA 0.04
- MACD
- DUO -0.14
- KTTA -0.00
- Stochastic Oscillator
- DUO 2.31
- KTTA 33.17
About DUO Fangdd Network Group Ltd.
Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).